190 related articles for article (PubMed ID: 21480386)
1. Involvement of VILIP-1 (visinin-like protein) and opposite roles of cyclic AMP and GMP signaling in in vitro cell migration of murine skin squamous cell carcinoma.
Schönrath K; Pan W; Klein-Szanto AJ; Braunewell KH
Mol Carcinog; 2011 May; 50(5):319-33. PubMed ID: 21480386
[TBL] [Abstract][Full Text] [Related]
2. The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.
Schönrath K; Klein-Szanto AJ; Braunewell KH
PLoS One; 2012; 7(3):e33116. PubMed ID: 22479362
[TBL] [Abstract][Full Text] [Related]
3. Visinin-like protein-1 is a potent inhibitor of cell adhesion and migration in squamous carcinoma cells.
Gonzalez Guerrico AM; Jaffer ZM; Page RE; Braunewell KH; Chernoff J; Klein-Szanto AJ
Oncogene; 2005 Mar; 24(14):2307-16. PubMed ID: 15735716
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the calcium sensor visinin-like protein-1 leads to a cAMP-mediated decrease of in vivo and in vitro growth and invasiveness of squamous cell carcinoma cells.
Mahloogi H; González-Guerrico AM; Lopez De Cicco R; Bassi DE; Goodrow T; Braunewell KH; Klein-Szanto AJ
Cancer Res; 2003 Aug; 63(16):4997-5004. PubMed ID: 12941826
[TBL] [Abstract][Full Text] [Related]
5. The neuronal Ca2+ sensor protein visinin-like protein-1 is expressed in pancreatic islets and regulates insulin secretion.
Dai FF; Zhang Y; Kang Y; Wang Q; Gaisano HY; Braunewell KH; Chan CB; Wheeler MB
J Biol Chem; 2006 Aug; 281(31):21942-21953. PubMed ID: 16731532
[TBL] [Abstract][Full Text] [Related]
6. Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology.
Braunewell KH; Dwary AD; Richter F; Trappe K; Zhao C; Giegling I; Schönrath K; Rujescu D
Transl Psychiatry; 2011 Jul; 1(7):e22. PubMed ID: 22832524
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
Kelly MP
Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
[TBL] [Abstract][Full Text] [Related]
8. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue.
Thibault G; Lacasse A; Garcia R
Life Sci; 1996; 58(25):2345-53. PubMed ID: 8649224
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
10. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP modulates the expression of Gi protein and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Anand-Srivastava MB
Cell Biochem Biophys; 2007; 47(1):99-108. PubMed ID: 17406063
[TBL] [Abstract][Full Text] [Related]
12. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
[TBL] [Abstract][Full Text] [Related]
13. The neuronal calcium-sensor protein VILIP modulates cyclic AMP accumulation in stably transfected C6 glioma cells: amino-terminal myristoylation determines functional activity.
Braunewell KH; Spilker C; Behnisch T; Gundelfinger ED
J Neurochem; 1997 May; 68(5):2129-39. PubMed ID: 9109541
[TBL] [Abstract][Full Text] [Related]
14. Intracellular neuronal calcium sensor (NCS) protein VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurones.
Braunewell KH; Brackmann M; Schaupp M; Spilker C; Anand R; Gundelfinger ED
J Neurochem; 2001 Sep; 78(6):1277-86. PubMed ID: 11579136
[TBL] [Abstract][Full Text] [Related]
15. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes.
Hemmrich K; Gummersbach C; Paul NE; Goy D; Suschek CV; Kröncke KD; Pallua N
Cytotherapy; 2010 Jul; 12(4):547-53. PubMed ID: 20370354
[TBL] [Abstract][Full Text] [Related]
17. Different effects of soluble and particulate guanylyl cyclases on expression of inflammatory cytokines in rat peripheral blood mononuclear cells.
Mitkiewicz M; Kuropatwa M; Kurowska E; Gorczyca WA
Immunobiology; 2011 Mar; 216(3):423-30. PubMed ID: 20656372
[TBL] [Abstract][Full Text] [Related]
18. Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus.
Wickborn C; Klein-Szanto AJ; Schlag PM; Braunewell KH
Mol Carcinog; 2006 Aug; 45(8):572-81. PubMed ID: 16683251
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
